levothyroxine sodium tablet
northwind pharmaceuticals - levothyroxine sodium (unii: 9j765s329g) (levothyroxine - unii:q51bo43mg4) - levothyroxine sodium anhydrous 0.1 mg - levothyroxine sodium is used for the following indications: hypothyroidism – as replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism. primary hypothyroidism may result from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation, or drugs, with or without the presence of goiter. pituitary tsh suppression – in the treatment or prevention of various types of euthyroid goiters (see warnings and precautions), including thyroid nodules (see warnings and precautions), subacute or chronic lymphocytic thyroiditis (hashimoto’s thyroiditis), multinodular goiter (see warnings and precautions) and, as an adjunct to surgery and radioiodine therapy in the management of thyr
levothyroxine sodium tablet
bryant ranch prepack - levothyroxine sodium (unii: 9j765s329g) (levothyroxine - unii:q51bo43mg4) - levothyroxine sodium anhydrous 200 ug - hypothyroidism levothyroxine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. pituitary thyrotropin (thyroid-stimulating hormone, tsh) suppression levothyroxine sodium tablets are indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. limitations of use: • levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium tablets may induce hyperthyroidism [see warnings and precautions (5.4)]. • levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. levothyroxine sodium tablets is contraindicated in patients with uncorrected adrenal insufficiency [see warnings and precauti
levothyroxine sodium aristo 125 micrograms tablets
aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium
levothyroxine sodium aristo 150 micrograms tablets
aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium
levothyroxine sodium aristo 75 micrograms tablets
aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium
levothyroxine sodium aristo 112 microgram tablets
aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium
levothyroxine sodium aristo 137 microgram tablets
aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium
levothyroxine sodium aristo 175 microgram tablets
aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium
levothyroxine sodium aristo 88 microgram tablets
aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium
levothyroxine clonmel
clonmel healthcare ltd - levothyroxine sodium - tablets - 25 microgram - levothyroxine sodium - thyroid hormones - treatment of benign euthyroid goitre. prophylaxis of relapse after surgery for euthyroid goitre, depending on the post-operative hormone status. substitution therapy in hypothyroidism. suppression therapy in thyroid cancer